Home
HelpTest ID TB2LN Susceptibility, Mycobacterium tuberculosis Complex, Second Line, Varies
Infectious
Useful For
Determination of Mycobacterium tuberculosis complex minimal inhibitory concentrations to second-line antimicrobial agents
Special Instructions
Method Name
Minimum Inhibitory Concentration (MIC) by Microtiter Broth Dilution Method
Reporting Name
Susceptibility, Mtb Complex, 2 LineSpecimen Type
VariesAdditional Testing Requirements
If organism identification is not provided, CTB / Mycobacteria and Nocardia Culture, Varies or CTBID / Culture Referred for Identification, Mycobacterium and Nocardia, Varies must also be ordered and will be charged separately.
Shipping Instructions
1. For shipping information see Infectious Specimen Shipping Guidelines.
2. Place specimen in a large infectious container and label as an etiologic agent/infectious substance.
Necessary Information
Specimen source and suspected organism identification are required.
Specimen Required
Specimen Type: Organism
Supplies: Infectious Container, Large (T146)
Container/Tube: Middlebrook 7H10 agar slant
Specimen Volume: Isolate
Collection Instructions: Organism must be in pure culture, actively growing.
Specimen Minimum Volume
See Specimen Required
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Varies | Ambient (preferred) | ||
| Refrigerated | |||
Reference Values
Interpretive criteria and reporting guidelines are followed using the Clinical Laboratory Standards Institute (CLSI) M24S document.
Day(s) Performed
Monday through Sunday
Performing Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
87186-Susceptibility, Mtb Cx, 2nd Line
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| TB2LN | Susceptibility, Mtb Complex, 2 Line | 29579-0 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| TB2LN | Susceptibility, Mtb Complex, 2 Line | 29579-0 |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Additional Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| STV2 | Susceptibility, Mtb Cx, 2nd Line | No, (Bill Only) | Yes |
Testing Algorithm
When this test is ordered, the additional test will always be performed at an additional charge.